Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03323580 : Effects of Intraoperative GDFT on the Postoperative Brain Edema
PhaseN/A
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

1. Preoperative brain image indicating high-grade glioma (HGG), verified by postoperative
histology of the World Health Organization (WHO) as grade III or IV tumors.

2. Age 18 -80 years.

3. Undergoing supratentorial brain tumour resection.

4. Signed informed consent.

Exclusion Criteria:

1. Renal insufficiency or the creatinine clearance is < 30 mL/kg.

2. Heart disease, New York Heart Association Functional Classification (NYHA) class II or
higher heart failure, or if their cardiac ejection fraction is < 20%.

3. Chronic obstructive pulmonary disease.

4. Extensive peripheral arterial occlusive disease.

5. Coagulopathy.

6. Surgery in the prone position.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03323580      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740